Lifeward Ltd. (LFWD)

Market Cap	16.30M
Revenue (ttm)	25.00M
Net Income (ttm)	-19.30M
Shares Out	8.81M
EPS (ttm)	-2.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,792
Open	1.790
Previous Close	1.840
Day's Range	1.760 - 1.881
52-Week Range	1.700 - 9.100
Beta	2.07
Analysts	Strong Buy
Price Target	13.00 (+602.7%)
Earnings Date	Nov 12, 2024

About LFWD

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological r...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 12, 2014
• Employees: 108
• Stock Exchange: NASDAQ
• Ticker Symbol: LFWD
• Website: https://golifeward.com

Financial Performance

In 2023, Lifeward's revenue was $13.85 million, an increase of 151.39% compared to the previous year's $5.51 million. Losses were -$22.13 million, 13.1% more than in 2022.

Analyst Forecast

According to one analyst, the rating for LFWD stock is "Strong Buy" and the 12-month stock price forecast is $13.0.

Price Target

$13.0

(602.70% upside)

Analyst Consensus: Strong Buy